Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness properties.

Pez F, Gifu P, Degli-Esposti D, Fares N, Lopez A, Lefrançois L, Michelet M, Rivoire M, Bancel B, Sylla BS, Herceg Z, Merle P, Caron de Fromentel C.

Exp Cell Res. 2019 Nov 15;384(2):111643. doi: 10.1016/j.yexcr.2019.111643. Epub 2019 Sep 23.

PMID:
31557464
2.

Primary Breast Burkitt's Lymphoma in an HIV-Infected Woman.

Traoré B, Fondrevelle ME, Condé M, Chassagne-Clément C, Kourouma T, Keita AM, Koulibaly M, Sylla BS.

Case Rep Med. 2015;2015:792041. doi: 10.1155/2015/792041. Epub 2015 May 27.

3.

Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.

Siouda M, Frecha C, Accardi R, Yue J, Cuenin C, Gruffat H, Manet E, Herceg Z, Sylla BS, Tommasino M.

PLoS Pathog. 2014 May 8;10(5):e1004125. doi: 10.1371/journal.ppat.1004125. eCollection 2014 May.

4.

Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis.

Mendy M, Caboux E, Sylla BS, Dillner J, Chinquee J, Wild C; BCNet survey participants.

Pathobiology. 2014;81(5-6):252-60. doi: 10.1159/000362093. Epub 2015 Mar 16.

5.

Human papillomavirus infection in women in four regions of Senegal.

Mbaye el HS, Gheit T, Dem A, McKay-Chopin S, Toure-Kane NC, Mboup S, Tommasino M, Sylla BS, Boye CS.

J Med Virol. 2014 Feb;86(2):248-56. doi: 10.1002/jmv.23719. Epub 2013 Sep 11.

PMID:
24026804
6.

Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.

Saidj D, Cros MP, Hernandez-Vargas H, Guarino F, Sylla BS, Tommasino M, Accardi R.

J Virol. 2013 Nov;87(22):12139-50. doi: 10.1128/JVI.01047-13. Epub 2013 Sep 4.

7.

The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.

Hasan UA, Zannetti C, Parroche P, Goutagny N, Malfroy M, Roblot G, Carreira C, Hussain I, Müller M, Taylor-Papadimitriou J, Picard D, Sylla BS, Trinchieri G, Medzhitov R, Tommasino M.

J Exp Med. 2013 Jul 1;210(7):1369-87. doi: 10.1084/jem.20122394. Epub 2013 Jun 10.

8.

Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.

Accardi R, Fathallah I, Gruffat H, Mariggiò G, Le Calvez-Kelm F, Voegele C, Bartosch B, Hernandez-Vargas H, McKay J, Sylla BS, Manet E, Tommasino M.

PLoS Pathog. 2013 Mar;9(3):e1003186. doi: 10.1371/journal.ppat.1003186. Epub 2013 Mar 14.

9.

HPV16 genetic variation and the development of cervical cancer worldwide.

Cornet I, Gheit T, Iannacone MR, Vignat J, Sylla BS, Del Mistro A, Franceschi S, Tommasino M, Clifford GM.

Br J Cancer. 2013 Jan 15;108(1):240-4. doi: 10.1038/bjc.2012.508. Epub 2012 Nov 20.

10.

Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.

Siouda M, Yue J, Shukla R, Guillermier S, Herceg Z, Creveaux M, Accardi R, Tommasino M, Sylla BS.

Mol Cell Biol. 2012 Dec;32(23):4877-90. doi: 10.1128/MCB.01050-12. Epub 2012 Oct 1.

11.

Prevalence of human papillomavirus types in cervical lesions from women in rural Western India.

Deodhar K, Gheit T, Vaccarella S, Romao CC, Tenet V, Nene BM, Jayant K, Kelkar R, Malvi SG, Sylla BS, Franceschi S, Jeronimo J, Shastri S, Sankaranarayanan R, Tommasino M.

J Med Virol. 2012 Jul;84(7):1054-60. doi: 10.1002/jmv.23310.

PMID:
22585722
12.

Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR.

Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM; IARC HPV Variant Study Group.

J Virol. 2012 Jun;86(12):6855-61. doi: 10.1128/JVI.00483-12. Epub 2012 Apr 4.

13.

DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract.

Mani S, Szymańska K, Cuenin C, Zaridze D, Balassiano K, Lima SC, Matos E, Daudt A, Koifman S, Filho VW, Menezes AM, Curado MP, Ferro G, Vaissière T, Sylla BS, Tommasino M, Pinto LF, Boffetta P, Hainaut P, Brennan P, Herceg Z.

Epigenetics. 2012 Mar;7(3):270-7. doi: 10.4161/epi.7.3.19306.

14.

Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.

Cornet I, Bouvard V, Campo MS, Thomas M, Banks L, Gissmann L, Lamartine J, Sylla BS, Accardi R, Tommasino M.

J Virol. 2012 Feb;86(4):2366-70. doi: 10.1128/JVI.06579-11. Epub 2011 Dec 14.

15.

Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Balassiano K, Lima S, Jenab M, Overvad K, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Canzian F, Kaaks R, Boeing H, Meidtner K, Trichopoulou A, Laglou P, Vineis P, Panico S, Palli D, Grioni S, Tumino R, Lund E, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Ramon Quirós J, Sánchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Hallmans G, Stenling R, Ehrnström R, Regner S, Allen NE, Travis RC, Khaw KT, Offerhaus GJ, Sala N, Riboli E, Hainaut P, Scoazec JY, Sylla BS, Gonzalez CA, Herceg Z.

Cancer Lett. 2011 Dec 1;311(1):85-95. doi: 10.1016/j.canlet.2011.06.038. Epub 2011 Jul 14.

PMID:
21831520
16.

A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent?

Sylla BS, Wild CP.

Int J Cancer. 2012 Jan 15;130(2):245-50. doi: 10.1002/ijc.26333. Epub 2011 Aug 30. Review.

17.

Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.

Saulnier A, Vaissière T, Yue J, Siouda M, Malfroy M, Accardi R, Creveaux M, Sebastian S, Shahzad N, Gheit T, Hussain I, Torrente M, Maffini FA, Calabrese L, Chiesa F, Cuenin C, Shukla R, Fathallah I, Matos E, Daudt A, Koifman S, Wünsch-Filho V, Menezes AM, Curado MP, Zaridze D, Boffetta P, Brennan P, Tommasino M, Herceg Z, Sylla BS.

Int J Cancer. 2012 Jun 1;130(11):2484-94. doi: 10.1002/ijc.26299. Epub 2011 Sep 22.

18.

Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2).

Parroche P, Touka M, Mansour M, Bouvard V, Thépot A, Accardi R, Carreira C, Roblot GG, Sylla BS, Hasan U, Tommasino M.

Virology. 2011 Sep 1;417(2):443-8. doi: 10.1016/j.virol.2011.05.016. Epub 2011 Jul 26.

19.

NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.

Hussain I, Fathallah I, Accardi R, Yue J, Saidj D, Shukla R, Hasan U, Gheit T, Niu Y, Tommasino M, Sylla BS.

J Virol. 2011 Sep;85(17):9013-22. doi: 10.1128/JVI.00002-11. Epub 2011 Jun 29.

20.

Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.

Yue J, Shukla R, Accardi R, Zanella-Cleon I, Siouda M, Cros MP, Krutovskikh V, Hussain I, Niu Y, Hu S, Becchi M, Jurdic P, Tommasino M, Sylla BS.

J Virol. 2011 Sep;85(17):8477-94. doi: 10.1128/JVI.02561-10. Epub 2011 Jun 22.

21.

E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.

Accardi R, Rubino R, Scalise M, Gheit T, Shahzad N, Thomas M, Banks L, Indiveri C, Sylla BS, Cardone RA, Reshkin SJ, Tommasino M.

J Virol. 2011 Aug;85(16):8208-16. doi: 10.1128/JVI.00114-11. Epub 2011 Jun 15.

22.

IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.

Accardi R, Scalise M, Gheit T, Hussain I, Yue J, Carreira C, Collino A, Indiveri C, Gissmann L, Sylla BS, Tommasino M.

Mol Cell Biol. 2011 Jun;31(11):2210-26. doi: 10.1128/MCB.00964-10. Epub 2011 Apr 11.

23.

Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling.

Shukla R, Yue J, Siouda M, Gheit T, Hantz O, Merle P, Zoulim F, Krutovskikh V, Tommasino M, Sylla BS.

Carcinogenesis. 2011 Jul;32(7):978-85. doi: 10.1093/carcin/bgr057. Epub 2011 Mar 31.

PMID:
21459755
24.

EBV latent membrane protein 1 is a negative regulator of TLR9.

Fathallah I, Parroche P, Gruffat H, Zannetti C, Johansson H, Yue J, Manet E, Tommasino M, Sylla BS, Hasan UA.

J Immunol. 2010 Dec 1;185(11):6439-47. doi: 10.4049/jimmunol.0903459. Epub 2010 Oct 27.

25.

NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction.

Textor S, Accardi R, Havlova T, Hussain I, Sylla BS, Gissmann L, Cerwenka A.

Int J Cancer. 2011 Mar 1;128(5):1104-13. doi: 10.1002/ijc.25442.

26.

HPV infection in women with and without cervical cancer in Conakry, Guinea.

Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S.

Br J Cancer. 2009 Jul 7;101(1):202-8. doi: 10.1038/sj.bjc.6605140. Epub 2009 Jun 16.

27.

Prevalence of human papillomavirus types in cervical and oral cancers in central India.

Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N.

Vaccine. 2009 Jan 29;27(5):636-9. doi: 10.1016/j.vaccine.2008.11.041. Epub 2008 Dec 3.

PMID:
19056450
28.

Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis.

Cazzaniga M, Gheit T, Casadio C, Khan N, Macis D, Valenti F, Miller MJ, Sylla BS, Akiba S, Bonanni B, Decensi A, Veronesi U, Tommasino M.

Breast Cancer Res Treat. 2009 Apr;114(3):599-605. doi: 10.1007/s10549-008-0040-3. Epub 2008 May 9.

PMID:
18465220
29.

Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints.

Dong W, Arpin C, Accardi R, Gissmann L, Sylla BS, Marvel J, Tommasino M.

Oncogene. 2008 May 1;27(20):2923-8. Epub 2007 Nov 19.

PMID:
18026133
30.

Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38.

Gabet AS, Accardi R, Bellopede A, Popp S, Boukamp P, Sylla BS, Londoño-Vallejo JA, Tommasino M.

FASEB J. 2008 Feb;22(2):622-32. Epub 2007 Sep 26.

PMID:
17898088
31.

Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types.

Gheit T, Billoud G, de Koning MN, Gemignani F, Forslund O, Sylla BS, Vaccarella S, Franceschi S, Landi S, Quint WG, Canzian F, Tommasino M.

J Clin Microbiol. 2007 Aug;45(8):2537-44. Epub 2007 Jun 20.

32.

E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.

Mansour M, Touka M, Hasan U, Bellopede A, Smet A, Accardi R, Gabet AS, Sylla BS, Tommasino M.

Virology. 2007 Oct 10;367(1):1-9. Epub 2007 Jun 12.

33.

A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.

Niu Y, Roy F, Saltel F, Andrieu-Soler C, Dong W, Chantegrel AL, Accardi R, Thépot A, Foiselle N, Tommasino M, Jurdic P, Sylla BS.

Mol Cell Biol. 2006 Jun;26(11):4288-301.

34.

Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.

Mansour M, Touka M, Malena A, Indiveri C, Dong W, Gionfriddo I, Accardi R, Paradiso A, Sylla BS, Gabet AS, Tommasino M.

Cancer Lett. 2007 Feb 8;246(1-2):274-81. Epub 2006 May 2.

PMID:
16650526
35.

Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.

Accardi R, Dong W, Smet A, Cui R, Hautefeuille A, Gabet AS, Sylla BS, Gissmann L, Hainaut P, Tommasino M.

EMBO Rep. 2006 Mar;7(3):334-40. Epub 2006 Jan 6.

36.

Dok1 expression and mutation in Burkitt's lymphoma cell lines.

Lee S, Huang H, Niu Y, Tommasino M, Lenoir G, Sylla BS.

Cancer Lett. 2007 Jan 8;245(1-2):44-50. Epub 2005 Dec 9.

PMID:
16338067
37.

Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.

Dong W, Kloz U, Accardi R, Caldeira S, Tong WM, Wang ZQ, Jansen L, Dürst M, Sylla BS, Gissmann L, Tommasino M.

J Virol. 2005 Dec;79(23):14899-908.

38.

Prevention of human cancer by modulation of chronic inflammatory processes.

Ohshima H, Tazawa H, Sylla BS, Sawa T.

Mutat Res. 2005 Dec 11;591(1-2):110-22. Epub 2005 Aug 3. Review.

PMID:
16083916
39.

IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Lee S, Andrieu C, Saltel F, Destaing O, Auclair J, Pouchkine V, Michelon J, Salaun B, Kobayashi R, Jurdic P, Kieff ED, Sylla BS.

Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17416-21. Epub 2004 Dec 1.

40.

Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.

Lee S, Roy F, Galmarini CM, Accardi R, Michelon J, Viller A, Cros E, Dumontet C, Sylla BS.

Oncogene. 2004 Mar 25;23(13):2287-97.

PMID:
14730347
41.

The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.

Sylla BS, Murphy K, Cahir-McFarland E, Lane WS, Mosialos G, Kieff E.

Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7470-5.

42.

SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.

Yin L, Ferrand V, Lavoué MF, Hayoz D, Philippe N, Souillet G, Seri M, Giacchino R, Castagnola E, Hodgson S, Sylla BS, Romeo G.

Hum Genet. 1999 Nov;105(5):501-5.

PMID:
10598819
43.

De novo retrotransposition of unbiased sequences in a human breast cancer cell clone.

Werle-Schneider G, von Brevern MC, Sylla BS, Hollstein MC.

Genes Chromosomes Cancer. 1999 Sep;26(1):84-91.

PMID:
10441010
44.

A new candidate region for the positional cloning of the XLP gene.

Bolino A, Yin L, Seri M, Cusano R, Cinti R, Coffey A, Brooksbank R, Howell G, Bentley D, Davis JR, Lanyi A, Huang D, Stark M, Creaven M, Bjørkhaug L, Heitzmann F, Lamartine J, Gaudi S, Sylla BS, Lenoir GM, Castagnola E, Giacchino R, Porta G, Franco B, Zollo M, Sumegi J, Romeo G.

Eur J Hum Genet. 1998 Sep-Oct;6(5):509-17.

45.

High-resolution mapping of the X-linked lymphoproliferative syndrome region by FISH on combed DNA.

Monier K, Michalet X, Lamartine J, Schurra C, Heitzmann F, Yin L, Cinti R, Sylla BS, Creaven M, Porta G, Vourc'h C, Robert-Nicoud M, Bensimon A, Romeo G.

Cytogenet Cell Genet. 1998;81(3-4):259-64.

PMID:
9730614
46.

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.

Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10106-11.

47.

Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.

Jäger M, Benninger-Döring G, Prang N, Sylla BS, Laumbacher B, Wank R, Wolf H, Schwarzmann F.

Int J Cancer. 1998 May 29;76(5):694-701.

48.

Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995.

Koulibaly M, Kabba IS, Cissé A, Diallo SB, Diallo MB, Keita N, Camara ND, Diallo MS, Sylla BS, Parkin DM.

Int J Cancer. 1997 Jan 6;70(1):39-45.

49.

Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4.

Lamartine J, Seri M, Cinti R, Heitzmann F, Creaven M, Radomski N, Jost E, Lenoir GM, Romeo G, Sylla BS.

Cytogenet Cell Genet. 1997;78(1):31-5.

PMID:
9345902
50.

Supplemental Content

Loading ...
Support Center